An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of chronic pain ...
Doctors say the studies may make healthcare providers more likely to prescribe federally approved medical cannabis for ...
A German study found a marijuana-based drug reduced chronic back pain. The low-dose THC formula improved pain, sleep, and function. Researchers say it could be a safer alternative to opioids.
President Donald Trump issued an executive order Thursday reclassifying marijuana as a Schedule III controlled substance, a change that does not legalize the drug at the federal level but could mean ...
Six or more prescriptions of anti-epileptic drug, gabapentin, for low back pain are linked to a significantly higher risk of developing dementia and mild cognitive impairment. The corresponding study ...
The anti-seizure drug gabapentin is used to treat epilepsy, nerve pain after shingles and restless legs syndrome by affecting chemical messengers in the brain and nerves. Common side effects include ...
Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis. Experts believe VER-01, and other similar drugs, could be a ...
Pharmacology, the science of drugs and how they affect our bodies, is constantly evolving. It brings us new and improved treatments for everyday ailments while shedding fresh light on the long-term ...
A Vertex Pharmaceuticals drug viewed as a successor to a non-opioid pill that won a landmark FDA approval earlier this year has failed a mid-stage clinical trial, dealing a setback to the company’s ...
Low back pain (LBP) is a prevalent condition associated with disability, work loss and economic burden to healthcare.
An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of chronic pain ...